The dual Syk/JAK inhibitor cerdulatinib antagonizes b-cell receptor and microenvironmental signaling in chronic lymphocytic leukemia

1. Blunt, M.D.
2. Koehrer, S.
3. Dobson, R.C.
4. Larrayoz, M.
5. Wilmore, S.
6. Hayman, A.
7. Parnell, J.
8. Smith, L.D.
9. Davies, A.
10. Johnson, P.W.M.
11. Conley, P.B.
12. Pandey, A.
13. Strefford, J.C.
14. Stevenson, F.K.
15. Packham, G.
16. Forconi, F.
17. Coffey, G.P.
18. Burger, J.A.
19. Steele, A.J.